Copyright Reports & Markets. All rights reserved.

Global Sendai Virus Reprogramming Kit Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Sendai Virus Reprogramming Kit Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Research Use Only Kits
    • 1.3.3 Clinical Research Grade Kits
    • 1.3.4 GMP-Manufactured Kits
  • 1.4 Market Analysis by Factor Combination
    • 1.4.1 Overview: Global Sendai Virus Reprogramming Kit Consumption Value by Factor Combination: 2021 Versus 2025 Versus 2032
    • 1.4.2 c-Myc Factor Kits
    • 1.4.3 L-Myc Factor Kits
    • 1.4.4 Custom Factor Kits
  • 1.5 Market Analysis by Vector Configuration
    • 1.5.1 Overview: Global Sendai Virus Reprogramming Kit Consumption Value by Vector Configuration: 2021 Versus 2025 Versus 2032
    • 1.5.2 Multi-Vector Kits
    • 1.5.3 Single-Vector Kits
    • 1.5.4 Custom Vector Kits
  • 1.6 Market Analysis by Cell Source
    • 1.6.1 Overview: Global Sendai Virus Reprogramming Kit Consumption Value by Cell Source: 2021 Versus 2025 Versus 2032
    • 1.6.2 Fibroblast Reprogramming Kits
    • 1.6.3 PBMC/Blood Reprogramming Kits
    • 1.6.4 Urine/Epithelial Cell Reprogramming Kits
    • 1.6.5 Broad Cell-Type Reprogramming Kits
  • 1.7 Market Analysis by Application
    • 1.7.1 Overview: Global Sendai Virus Reprogramming Kit Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.7.2 iPSC Line Derivation
    • 1.7.3 Disease Modeling
    • 1.7.4 Drug Screening and Toxicology
    • 1.7.5 Cell Therapy Process Development
    • 1.7.6 iPSC Banking
    • 1.7.7 Gene Editing and Cell Line Engineering
  • 1.8 Global Sendai Virus Reprogramming Kit Market Size & Forecast
    • 1.8.1 Global Sendai Virus Reprogramming Kit Consumption Value (2021 & 2025 & 2032)
    • 1.8.2 Global Sendai Virus Reprogramming Kit Sales Quantity (2021-2032)
    • 1.8.3 Global Sendai Virus Reprogramming Kit Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Thermo Fisher Scientific
    • 2.1.1 Thermo Fisher Scientific Details
    • 2.1.2 Thermo Fisher Scientific Major Business
    • 2.1.3 Thermo Fisher Scientific Sendai Virus Reprogramming Kit Product and Services
    • 2.1.4 Thermo Fisher Scientific Sendai Virus Reprogramming Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Thermo Fisher Scientific Recent Developments/Updates
  • 2.2 ID Pharma
    • 2.2.1 ID Pharma Details
    • 2.2.2 ID Pharma Major Business
    • 2.2.3 ID Pharma Sendai Virus Reprogramming Kit Product and Services
    • 2.2.4 ID Pharma Sendai Virus Reprogramming Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 ID Pharma Recent Developments/Updates
  • 2.3 Melton Biomedtech
    • 2.3.1 Melton Biomedtech Details
    • 2.3.2 Melton Biomedtech Major Business
    • 2.3.3 Melton Biomedtech Sendai Virus Reprogramming Kit Product and Services
    • 2.3.4 Melton Biomedtech Sendai Virus Reprogramming Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Melton Biomedtech Recent Developments/Updates

3 Competitive Environment: Sendai Virus Reprogramming Kit by Manufacturer

  • 3.1 Global Sendai Virus Reprogramming Kit Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Sendai Virus Reprogramming Kit Revenue by Manufacturer (2021-2026)
  • 3.3 Global Sendai Virus Reprogramming Kit Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Sendai Virus Reprogramming Kit by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Sendai Virus Reprogramming Kit Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Sendai Virus Reprogramming Kit Manufacturer Market Share in 2025
  • 3.5 Sendai Virus Reprogramming Kit Market: Overall Company Footprint Analysis
    • 3.5.1 Sendai Virus Reprogramming Kit Market: Region Footprint
    • 3.5.2 Sendai Virus Reprogramming Kit Market: Company Product Type Footprint
    • 3.5.3 Sendai Virus Reprogramming Kit Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Sendai Virus Reprogramming Kit Market Size by Region
    • 4.1.1 Global Sendai Virus Reprogramming Kit Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Sendai Virus Reprogramming Kit Consumption Value by Region (2021-2032)
    • 4.1.3 Global Sendai Virus Reprogramming Kit Average Price by Region (2021-2032)
  • 4.2 North America Sendai Virus Reprogramming Kit Consumption Value (2021-2032)
  • 4.3 Europe Sendai Virus Reprogramming Kit Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Sendai Virus Reprogramming Kit Consumption Value (2021-2032)
  • 4.5 South America Sendai Virus Reprogramming Kit Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Sendai Virus Reprogramming Kit Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Sendai Virus Reprogramming Kit Sales Quantity by Type (2021-2032)
  • 5.2 Global Sendai Virus Reprogramming Kit Consumption Value by Type (2021-2032)
  • 5.3 Global Sendai Virus Reprogramming Kit Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Sendai Virus Reprogramming Kit Sales Quantity by Application (2021-2032)
  • 6.2 Global Sendai Virus Reprogramming Kit Consumption Value by Application (2021-2032)
  • 6.3 Global Sendai Virus Reprogramming Kit Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Sendai Virus Reprogramming Kit Sales Quantity by Type (2021-2032)
  • 7.2 North America Sendai Virus Reprogramming Kit Sales Quantity by Application (2021-2032)
  • 7.3 North America Sendai Virus Reprogramming Kit Market Size by Country
    • 7.3.1 North America Sendai Virus Reprogramming Kit Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Sendai Virus Reprogramming Kit Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Sendai Virus Reprogramming Kit Sales Quantity by Type (2021-2032)
  • 8.2 Europe Sendai Virus Reprogramming Kit Sales Quantity by Application (2021-2032)
  • 8.3 Europe Sendai Virus Reprogramming Kit Market Size by Country
    • 8.3.1 Europe Sendai Virus Reprogramming Kit Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Sendai Virus Reprogramming Kit Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Sendai Virus Reprogramming Kit Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Sendai Virus Reprogramming Kit Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Sendai Virus Reprogramming Kit Market Size by Region
    • 9.3.1 Asia-Pacific Sendai Virus Reprogramming Kit Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Sendai Virus Reprogramming Kit Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Sendai Virus Reprogramming Kit Sales Quantity by Type (2021-2032)
  • 10.2 South America Sendai Virus Reprogramming Kit Sales Quantity by Application (2021-2032)
  • 10.3 South America Sendai Virus Reprogramming Kit Market Size by Country
    • 10.3.1 South America Sendai Virus Reprogramming Kit Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Sendai Virus Reprogramming Kit Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Sendai Virus Reprogramming Kit Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Sendai Virus Reprogramming Kit Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Sendai Virus Reprogramming Kit Market Size by Country
    • 11.3.1 Middle East & Africa Sendai Virus Reprogramming Kit Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Sendai Virus Reprogramming Kit Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Sendai Virus Reprogramming Kit Market Drivers
  • 12.2 Sendai Virus Reprogramming Kit Market Restraints
  • 12.3 Sendai Virus Reprogramming Kit Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Sendai Virus Reprogramming Kit and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Sendai Virus Reprogramming Kit
  • 13.3 Sendai Virus Reprogramming Kit Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Sendai Virus Reprogramming Kit Typical Distributors
  • 14.3 Sendai Virus Reprogramming Kit Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Sendai Virus Reprogramming Kit market size was valued at US$ 57.62 million in 2025 and is forecast to a readjusted size of US$ 109 million by 2032 with a CAGR of 9.4% during review period.
    Sendai virus reprogramming kits are iPSC induction systems based on replication-defective or temperature-sensitive Sendai virus (SeV) RNA vectors used to deliver key reprogramming factors such as OCT4, SOX2, KLF4, c-MYC, and/or L-MYC. These kits enable efficient conversion of somatic cells—including fibroblasts, peripheral blood mononuclear cells (PBMCs), T cells, and urine-derived cells—into induced pluripotent stem cells (iPSCs). The main technical advantages include non-integrating cytoplasmic expression, high reprogramming efficiency, and reduced manipulation steps. Because SeV is not integrated into the host genome, downstream workflows require vector clearance and residual SeV detection assays. The products are typically offered in RUO, clinical research-grade, or GMP-manufacturing-compatible formats and are used by academic institutions, CRO/CDMOs, and cell therapy developers. The estimated gross margin is approximately 68%.
    The downstream demand mainly comes from patient-specific iPSC generation, disease modeling, drug screening and early-stage cell therapy process development. With the increasing development of iPSC-derived cell therapies, genetic disease models and outsourced iPSC generation projects by pharmaceutical companies, customers are placing greater emphasis on non-integrating, high success rate and traceable workflows, driving Sendai virus-based solutions to maintain strong purchasing stickiness in high-value sample applications and preclinical translational research.
    Product upgrades focus on safer factor combinations, rapidly removable SeV vectors, stable high-titer production, xeno-free formulations and supporting residual detection. The global supply landscape remains dominated by a limited number of manufacturers with SeV vector patents, production experience and quality control systems. Clinical research-grade products require GMP environments, batch release testing, sterility testing, mycoplasma testing, endotoxin testing and viral titer evaluation, resulting in significantly higher entry barriers compared with conventional reprogramming reagents.
    Demand in North America, Europe and Japan is concentrated in high-confidence iPSC generation platforms and cell therapy development, while the Chinese market is driven by import substitution and increasing investment in domestic iPSC research. Major risks come from the substitution pressure of non-viral approaches such as mRNA, circular RNA and episomal vectors in terms of cost, virus-free residual profiles and automation. However, Sendai virus technology remains suitable for challenging samples and standardized cell line generation projects due to its advantages in high efficiency, single transduction capability and compatibility with multiple cell sources.
    Report Scope
    This report is a detailed and comprehensive analysis for global Sendai Virus Reprogramming Kit market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Sendai Virus Reprogramming Kit market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Sendai Virus Reprogramming Kit market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Sendai Virus Reprogramming Kit market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Sendai Virus Reprogramming Kit market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Sendai Virus Reprogramming Kit
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Sendai Virus Reprogramming Kit market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, ID Pharma, Melton Biomedtech, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Sendai Virus Reprogramming Kit market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Research Use Only Kits
    Clinical Research Grade Kits
    GMP-Manufactured Kits
    Market segment by Factor Combination
    c-Myc Factor Kits
    L-Myc Factor Kits
    Custom Factor Kits
    Market segment by Vector Configuration
    Multi-Vector Kits
    Single-Vector Kits
    Custom Vector Kits
    Market segment by Cell Source
    Fibroblast Reprogramming Kits
    PBMC/Blood Reprogramming Kits
    Urine/Epithelial Cell Reprogramming Kits
    Broad Cell-Type Reprogramming Kits
    Market segment by Application
    iPSC Line Derivation
    Disease Modeling
    Drug Screening and Toxicology
    Cell Therapy Process Development
    iPSC Banking
    Gene Editing and Cell Line Engineering
    Major players covered
    Thermo Fisher Scientific
    ID Pharma
    Melton Biomedtech
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    Chapter Outline
    Chapter 1, to describe Sendai Virus Reprogramming Kit product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Sendai Virus Reprogramming Kit, with price, sales quantity, revenue, and global market share of Sendai Virus Reprogramming Kit from 2021 to 2026.
    Chapter 3, the Sendai Virus Reprogramming Kit competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Sendai Virus Reprogramming Kit breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Sendai Virus Reprogramming Kit market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Sendai Virus Reprogramming Kit.
    Chapter 14 and 15, to describe Sendai Virus Reprogramming Kit sales channel, distributors, customers, research findings and conclusion.

    Buy now